Literature DB >> 30745380

Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient.

Brady S Moffett1,2, Vijay Ivaturi3, Jennifer Morris4,2, Ayse Akcan Arikan2, Ankhi Dutta2.   

Abstract

The most appropriate vancomycin dosing strategy in pediatric patients weighing ≥70 kg (weight based versus non-weight based) to achieve an area under the concentration-time curve (AUC) of ≥400 mg·liter/h and a trough concentration of <20 mg/liter is not known. Population pharmacokinetic analysis determined that dosing of vancomycin should be weight based using fat-free mass, with appropriate adjustment for kidney dysfunction.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  obesity; pediatrics; population pharmacokinetics; vancomycin

Mesh:

Substances:

Year:  2019        PMID: 30745380      PMCID: PMC6437517          DOI: 10.1128/AAC.02359-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Commentary on significance levels for covariate effects in NONMEM.

Authors:  Stuart L Beal
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-08       Impact factor: 2.745

2.  Vancomycin dosing in obese pediatric patients.

Authors:  Brady S Moffett; Shelly Kim; Morven S Edwards
Journal:  Clin Pediatr (Phila)       Date:  2011-01-31       Impact factor: 1.168

Review 3.  Diagnosing model diagnostics.

Authors:  M O Karlsson; R M Savic
Journal:  Clin Pharmacol Ther       Date:  2007-07       Impact factor: 6.875

4.  Vancomycin dosage in overweight and obese children.

Authors:  Misty Miller; Jamie L Miller; Tracy M Hagemann; Donald Harrison; Susana Chavez-Bueno; Peter N Johnson
Journal:  Am J Health Syst Pharm       Date:  2011-11-01       Impact factor: 2.637

5.  Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014.

Authors:  Cynthia L Ogden; Margaret D Carroll; Hannah G Lawman; Cheryl D Fryar; Deanna Kruszon-Moran; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

6.  Bayesian Estimation of Vancomycin Pharmacokinetics in Obese Children: Matched Case-Control Study.

Authors:  Jennifer Le; Edmund V Capparelli; Uzra Wahid; Yi Shuan S Wu; Gale L Romanowski; Tri M Tran; Austin Nguyen; John S Bradley
Journal:  Clin Ther       Date:  2015-05-29       Impact factor: 3.393

7.  Prediction of Fat-Free Mass in Children.

Authors:  Hesham Saleh Al-Sallami; Ailsa Goulding; Andrea Grant; Rachael Taylor; Nicholas Holford; Stephen Brent Duffull
Journal:  Clin Pharmacokinet       Date:  2015-11       Impact factor: 6.447

8.  Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.

Authors:  Chad A Knoderer; Allison L Gritzman; Kristen R Nichols; Amy C Wilson
Journal:  Ann Pharmacother       Date:  2015-07-09       Impact factor: 3.154

9.  Improved vancomycin dosing in children using area under the curve exposure.

Authors:  Jennifer Le; John S Bradley; William Murray; Gale L Romanowski; Tu T Tran; Natalie Nguyen; Susan Cho; Stephanie Natale; Ivilynn Bui; Tri M Tran; Edmund V Capparelli
Journal:  Pediatr Infect Dis J       Date:  2013-04       Impact factor: 2.129

10.  New equations to estimate GFR in children with CKD.

Authors:  George J Schwartz; Alvaro Muñoz; Michael F Schneider; Robert H Mak; Frederick Kaskel; Bradley A Warady; Susan L Furth
Journal:  J Am Soc Nephrol       Date:  2009-01-21       Impact factor: 10.121

View more
  1 in total

1.  Population Pharmacokinetics of Vancomycin in Kidney Transplant Recipients: Model Building and Parameter Optimization.

Authors:  Kui-Fen Ma; Yi-Xi Liu; Zheng Jiao; Jun-Hao Lv; Ping Yang; Jian-Yong Wu; Si Yang
Journal:  Front Pharmacol       Date:  2020-10-06       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.